Intertrochanteric Fracture

Last updated: November 25, 2025
Table Of Contents

Intertrochanteric Fracture

Intertrochanteric fractures are extracapsular fractures of the proximal femur that occur between the greater and lesser trochanter. There is an area of low bone mineral density known as the ward triangle bordered by the primary compressive trabeculae, principal tensile trabeculae and secondary compressive trabeculae (between the neck and lateral cortex adjacent to the trochanter on imaging). This area is prone to fracture, especially in individuals with osteoporosis.

Intertrochanteric fractures are easier to heal and less likely to result in avascular necrosis compared to femoral neck fractures. They are common in the elderly, usually following falls from standing height. Treatment is usually operative.

Intertrochanteric fractures account for 50% of proximal femur fractures. The average age is 80 years old. It affects women more than men.

Evans classification of intertrochanteric fracture (based on post-reduction stability)

ClassificationDescription
StableStable since the posteromedial cortex intact. It is able to resist compressive load
UnstableUnstable due to significant comminution of posteromedial cortex
Reverse obliquityUnstable since the femoral shaft is displaced medially by the adductors

Boyd and Griffin classification of intertrochanteric fracture (based on the degree of displacement and comminution)

ClassificationDescription
Type INon-displaced fracture along the intertrochanteric line
Type IIDisplaced or comminuted along the intertrochanteric line
Type IIIComminuted intertrochanteric fracture with subtrochanteric extension
Type IVReverse obliquity with extension into subtrochanteric region

Tronzo classification (based on fracture stability and pattern)

ClassificationDescription
Type IIncomplete fracture involving the greater trochanter. Stable
Type IINon-comminuted fracture with intact posterior wall and small lesser trochanter fragment. Stable
Type IIIComminuted posterior wall with telescoping of the fragments (neck spike and shaft) and a large lesser trochanter fragment. Unstable
Type IVComminuted posterior wall without telescoping. The neck spike is displaced outside the shaft. Most of the posterior wall is lost medially. Unstable
Type VReverse oblique fracture with medial displacement of the shaft. Very unstable
  • Risk factors
    • Proximal humerus fracture
    • Osteoporosis
    • Advanced age
    • Comorbidities e.g. dementia, parkinsons
    • High dependency with activities of daily living
  • Mechanism of injury
    • Low-energy e.g. fall from standing height in osteoporotic patients
    • High-energy trauma in young patients
  • Associated conditions
  • Signs and symptoms
    • Severe pain along the entire hip region
    • Deformity (similar to hip fracture): external rotation and limb shortening
    • Inability to bear weight
    • Pain with log roll and axial load
    • Unable to perform active straight leg raise
  • Investigations
    • X-ray (AP pelvis, AP hip, cross table lateral and full length femur): to compare contralateral hip, assess neck shaft angle and define fracture pattern
    • CT scan: to assess for occult fractures
    • MRI: for occult fractures
    • Bone scan: for occult fractures if MRI is contraindicated
  • Indications for non-operative treatment
    • Non-ambulatory patient
    • High-risk of peri-operative mortality
    • Skin breakdown at surgical site
    • Incomplete fracture
  • Indications for operative treatment
    • Stable or unstable fracture in fit patients
    • Severly comminuted fractures (arthroplasty)
    • Pre-existing severe degenerative hip disease (arthroplasty)
    • Severe osteoporosis (arthroplasty)
  • Non-operative treatment
    • Non-weight bearing + early mobilization (bed to chair)
    • Protected weight bearing
  • Operative treatment
    • Closed reduction and intramedullary nail fixation
    • Open reduction and internal fixation (ORIF)
      • Sliding hip screw
      • Proximal femur locking plate
    • Arthroplasty
  • Prognosis
    • Correlates to how quickly safe surgery is performed
    • Mortality decreases if surgery is performed within 48 hours
  • Complications
Reference Intervals
Biochemistry
ACTHP: <80 ng/L
ALTP: 5–35 U/L
AlbuminP: 35–50 g/L
AldosteroneP: 100–500 pmol/L
Alk. phosphataseP: 30–130 U/L
α-AmylaseP: 0–180 IU/dL
α-FetoproteinS: <10 kU/L
Angiotensin IIP: 5–35 pmol/L
ADHP: 0.9–4.6 pmol/L
ASTP: 5–35 U/L
BicarbonateP: 24–30 mmol/L
BilirubinP: 3–17 μmol/L
BNPP: <50 ng/L
CRPP: <10 mg/L
CalcitoninP: <0.1 mcg/L
Calcium (ionized)P: 1.0–1.25 mmol/L
Calcium (total)P: 2.12–2.60 mmol/L
ChlorideP: 95–105 mmol/L
CholesterolP: <5.0 mmol/L
VLDLP: 0.128–0.645 mmol/L
LDLP: <2.0 mmol/L
HDLP: 0.9–1.93 mmol/L
Cortisol AMP: 450–700 nmol/L
Cortisol MidnightP: 80–280 nmol/L
CK ♂P: 25–195 U/L
CK ♀P: 25–170 U/L
CreatinineP: 70–100 μmol/L
FerritinP: 12–200 mcg/L
FolateS: 2.1 mcg/L
FSHP: 2–8 U/L ♂; >25 menopause
GGT ♂P: 11–51 U/L
GGT ♀P: 7–33 U/L
Glucose (fasting)P: 3.5–5.5 mmol/L
Growth hormoneP: <20 mu/L
HbA1C (DCCT)B: 4–6%
HbA1C (IFCC)B: 20–42 mmol/mol
Iron ♂S: 14–31 μmol/L
Iron ♀S: 11–30 μmol/L
Lactate (venous)P: 0.6–2.4 mmol/L
Lactate (arterial)P: 0.6–1.8 mmol/L
LDHP: 70–250 U/L
LHP: 3–16 U/L
MagnesiumP: 0.75–1.05 mmol/L
OsmolalityP: 278–305 mosmol/kg
PTHP: 0.8–8.5 pmol/L
PotassiumP: 3.5–5.3 mmol/L
Prolactin ♂P: <450 U/L
Prolactin ♀P: <600 U/L
PSAP: 0–4 mcg/mL
Protein (total)P: 60–80 g/L
Red cell folateB: 0.36–1.44 μmol/L
Renin (erect)P: 2.8–4.5 pmol/mL/h
Renin (recumbent)P: 1.1–2.7 pmol/mL/h
SodiumP: 135–145 mmol/L
TBGP: 7–17 mg/L
TSHP: 0.5–4.2 mU/L
T4P: 70–140 nmol/L
Free T4P: 9–22 pmol/L
TIBCS: 54–75 μmol/L
TriglyceridesP: 0.50–2.3 mmol/L
T3P: 1.2–3.0 nmol/L
Troponin TP: <0.1 mcg/L
Urate ♂P: 210–480 μmol/L
Urate ♀P: 150–390 μmol/L
UreaP: 2.5–6.7 mmol/L
Vitamin B12S: 0.13–0.68 nmol/L
Vitamin DS: 50 nmol/L
Arterial Blood Gases
pH7.35–7.45
PaCO₂4.7–6.0 kPa
PaO₂>10.6 kPa
Base excess±2 mmol/L
Urine
Cortisol (free)<280 nmol/24h
Hydroxyindole acetic acid16–73 μmol/24h
Hydroxymethylmandelic acid16–48 μmol/24h
Metanephrines0.03–0.69 μmol/mmol cr.
Osmolality350–1000 mosmol/kg
17-Oxogenic steroids ♂28–30 μmol/24h
17-Oxogenic steroids ♀21–66 μmol/24h
17-Oxosteroids ♂17–76 μmol/24h
17-Oxosteroids ♀14–59 μmol/24h
Phosphate (inorganic)15–50 mmol/24h
Potassium14–120 mmol/24h
Protein<150 mg/24h
Protein/creatinine ratio<3 mg/mmol
Sodium100–250 mmol/24h
Haematology
WCC4.0–11.0 ×10⁹/L
RBC ♂4.5–6.5 ×10¹²/L
RBC ♀3.9–5.6 ×10¹²/L
Hb ♂130–180 g/L
Hb ♀115–160 g/L
PCV ♂0.4–0.54 L/L
PCV ♀0.37–0.47 L/L
MCV76–96 fL
MCH27–32 pg
MCHC300–360 g/L
RDW11.6–14.6%
Neutrophils2.0–7.5 ×10⁹/L (40–75%)
Lymphocytes1.0–4.5 ×10⁹/L (20–45%)
Eosinophils0.04–0.44 ×10⁹/L (1–6%)
Basophils0–0.10 ×10⁹/L (0–1%)
Monocytes0.2–0.8 ×10⁹/L (2–10%)
Platelets150–400 ×10⁹/L
Reticulocytes0.8–2.0% / 25–100 ×10⁹/L
Prothrombin time10–14 s
APTT35–45 s
Paediatric
Pulse Rate (bpm)
Neonate140–160
Infant <1yr120–140
1–5 years110–130
5–12 years80–120
>12 years70–100
Respiratory Rate (tachypnoea)
0–2 months≥60/min
2–12 months≥50/min
1–5 years≥40/min
>5 years≥30/min
Blood Pressure (mmHg)
Term65/45
1 year75/50
4 years85/60
8 years95/65
10 years100/70
Weight Formulas
3–12 months(a + 9)/2 kg
1–6 years2a + 8 kg
>6 years(7a − 5)/2 kg
Haemoglobin (g/dL)
Term newborn13–20
1 month11–18
2 months10–15
1–2 years10–13
>2 years11–14
MUAC (6 months–5 years)
Obese>17.5 cm
Normal13.5–17.4 cm
At risk12.5–13.4 cm
Moderate malnutrition11.5–12.4 cm
Severe malnutrition<11.5 cm
Developmental Milestones
Social smile1.5 months
Head control4 months
Sits unsupported7 months
Crawls10 months
Stands unsupported10–12 months
Walks12–13 months
Talks18 months
CSF WBC (/mm³)
Term newborn0–25
>2 weeks0–5
Calculator

Post Discussion

Your email address will not be published. Required fields are marked *